2014
DOI: 10.1016/j.ejmech.2014.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Antimycobacterial activity of chiral aminoalcohols with camphane scaffold

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 12 publications
0
13
0
Order By: Relevance
“…Monoterpenoid‐based agent SQ 109 (Figure ), combining 2‐adamantylamine and geranylamine, is a novel anti‐TB drug candidate with a unique multimodal mechanism of action . Recently, we have reported a series of studies focused on the synthesis of antituberculosis agents containing the bicyclo[2.2.1]heptane framework fragment . The latter is combined with a number of pharmacophore groups resulting in improved physiological and pharmacological properties.…”
Section: Introductionmentioning
confidence: 99%
“…Monoterpenoid‐based agent SQ 109 (Figure ), combining 2‐adamantylamine and geranylamine, is a novel anti‐TB drug candidate with a unique multimodal mechanism of action . Recently, we have reported a series of studies focused on the synthesis of antituberculosis agents containing the bicyclo[2.2.1]heptane framework fragment . The latter is combined with a number of pharmacophore groups resulting in improved physiological and pharmacological properties.…”
Section: Introductionmentioning
confidence: 99%
“…Surgical excision and reconstruction are often required in very serious cases. Atypical Mycobacterium infections can be treated with a variety of antibiotics, although treatment is difficult, due to these organisms often being resistant to regular TB medication [25,38,7,13,44,46,14,107,111,56,20].…”
Section: Discussionmentioning
confidence: 99%
“…Phase one treatment consists of INH, RIF, EMB and PZA for 2 months, followed by 4 months' treatment with INH and RIF in phase two. If INH resistance is suspected, EMB can also be given in phase two [22,6,47,38,13,14,29,65,56,34,20,35,30].…”
Section: True Cutaneous Tuberculosis and Tuberculidsmentioning
confidence: 99%
“…Among the synthesized compounds, N -geranyl- N ′-(2-adamanthan-1-yl)ethane-1,2-diamine ( Figure 1 c) showed promising efficiency [ 12 ]. The outlined systematic research led to N -ArPA molecules ( Figure 1 d), in which structure the distance between two nitrogens, presence of β -aminoalcohol motifs and short connecting chains were crucial for their in vitro antimycobacterial activity [ 13 ]. The derivatives N -ArPA were very effective against Mycobacterium tuberculosis CNCTC My 331/88 (identical with M. tuberculosis H 37 R v ) and multi-drug resistant (MDR) M. tuberculosis 43 strain, which showed resistance to rifampicin (RIF) and isoniazid (INH).…”
Section: Introductionmentioning
confidence: 99%
“…It was also concluded that removal or significant alteration of basicity of either amino group led to loss of potency [ 9 , 13 ]. In addition, the presence of the R = 2-/4-F substituent and OH group with the ( R )-configuration at the carbon of a connecting chain ( Figure 1 d) resulted in higher in vitro antimycobacterial efficiency than in a case of EMB.…”
Section: Introductionmentioning
confidence: 99%